• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

STAT1 负调控肝癌细胞增殖。

STAT1 negatively regulates hepatocellular carcinoma cell proliferation.

机构信息

Department of General Surgery, the First Hospital of Jilin University, Changchun, Jilin 130021, PR China.

出版信息

Oncol Rep. 2013 Jun;29(6):2303-10. doi: 10.3892/or.2013.2398. Epub 2013 Apr 9.

DOI:10.3892/or.2013.2398
PMID:23588992
Abstract

Signal transducer and activator of transcription 1 (STAT1) regulates cell proliferation and survival. The present study aimed to investigate the role of STAT1 in the development and progression of human hepatocellular carcinoma (HCC). The levels of STAT1 expression in 36 HCC and 12 non-HCC liver tissues were examined by immunohistochemistry. The effect of STAT1 overexpression or silencing on the proliferation and apoptosis of HCC cells was determined by MTT and flow cytometric assays. The effect of STAT1 overexpression or silencing on the levels of p53 and cyclin E expression was determined by quantitative PCR and western blot assays. The level of STAT1 expression in the HCC tissues was significantly lower compared to the level in the non-HCC liver tissues and was negatively associated with the histological grade of HCC and serum HBsAg, anti-HCV and α-fetoprotein positivity in HCC patients. Induction of STAT1 overexpression significantly inhibited HepG2 cell proliferation and enhanced HCC cell apoptosis, accompanied by upregulation of p53 expression and STAT1 phosphorylation, but a reduction in cyclin E expression in HepG2 cells. In contrast, knockdown of STAT1 by introduction of STAT1-specific siRNA promoted HepG2 cell proliferation, but inhibited HCC cell apoptosis, accompanied by significant downregulation of p53 expression, but enhancement of cyclin E expression in vitro. Our data suggest that STAT1 may inhibit HCC growth by regulating p53-related cell cycling and apoptosis.

摘要

信号转导子和转录激活子 1(STAT1)调节细胞增殖和存活。本研究旨在探讨 STAT1 在人类肝细胞癌(HCC)发生和发展中的作用。通过免疫组织化学法检测 36 例 HCC 和 12 例非 HCC 肝组织中 STAT1 的表达水平。通过 MTT 和流式细胞术检测 STAT1 过表达或沉默对 HCC 细胞增殖和凋亡的影响。通过定量 PCR 和 Western blot 检测 STAT1 过表达或沉默对 p53 和细胞周期蛋白 E 表达水平的影响。与非 HCC 肝组织相比,HCC 组织中 STAT1 的表达水平明显降低,且与 HCC 患者的组织学分级以及血清 HBsAg、抗 HCV 和 α-胎蛋白阳性呈负相关。诱导 STAT1 过表达显著抑制 HepG2 细胞增殖并增强 HCC 细胞凋亡,同时伴有 p53 表达和 STAT1 磷酸化上调,但细胞周期蛋白 E 表达下调。相反,通过引入 STAT1 特异性 siRNA 敲低 STAT1 促进 HepG2 细胞增殖,但抑制 HCC 细胞凋亡,同时伴有 p53 表达显著下调,但细胞周期蛋白 E 表达上调。我们的数据表明,STAT1 可能通过调节 p53 相关的细胞周期和凋亡来抑制 HCC 的生长。

相似文献

1
STAT1 negatively regulates hepatocellular carcinoma cell proliferation.STAT1 负调控肝癌细胞增殖。
Oncol Rep. 2013 Jun;29(6):2303-10. doi: 10.3892/or.2013.2398. Epub 2013 Apr 9.
2
Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.肝癌中 p53 诱导的抗增殖基因 BTG2 的异常表达与细胞周期相关蛋白的过度表达有关。
Cell Biochem Biophys. 2011 Sep;61(1):83-91. doi: 10.1007/s12013-011-9164-x.
3
Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.抑制结缔组织生长因子过表达可减少肝癌细胞在体外和体内的生长。
Chin Med J (Engl). 2011 Nov;124(22):3794-9.
4
[Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].RNA干扰抑制SMYD3基因表达诱导人肝癌细胞系HepG2凋亡
Ai Zheng. 2006 May;25(5):526-32.
5
Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.辛伐他汀通过上调Notch1表达诱导HepG2和Huh7肝癌细胞的生长抑制和凋亡。
Mol Med Rep. 2015 Mar;11(3):2334-40. doi: 10.3892/mmr.2014.2976. Epub 2014 Nov 19.
6
shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.shRNA 介导的 Gli2 基因沉默抑制增殖并增强人肝癌细胞对 TRAIL 诱导的凋亡敏感性。
J Cell Biochem. 2011 Nov;112(11):3140-50. doi: 10.1002/jcb.23240.
7
Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.Notch1信号通路通过诱导细胞周期停滞和凋亡来抑制人肝细胞癌的生长。
Cancer Res. 2003 Dec 1;63(23):8323-9.
8
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.Mybl2 的表达受遗传控制,并有助于决定肝癌易感表型。
J Hepatol. 2011 Jul;55(1):111-9. doi: 10.1016/j.jhep.2010.10.031. Epub 2010 Dec 7.
9
Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.在人肝癌中过表达的核 BAG-1 与不良预后和多柔比星耐药性相关。
J Cell Biochem. 2013 Sep;114(9):2120-30. doi: 10.1002/jcb.24560.
10
Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.CDC20表达增加与肝细胞癌的发生和进展相关。
Int J Oncol. 2014 Oct;45(4):1547-55. doi: 10.3892/ijo.2014.2559. Epub 2014 Jul 24.

引用本文的文献

1
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade.利用新型溶瘤朱罗纳病毒和免疫检查点阻断增强肝细胞癌的免疫反应和生存率。
Mol Ther Oncol. 2024 Nov 26;32(4):200913. doi: 10.1016/j.omton.2024.200913. eCollection 2024 Dec 19.
2
Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma.检测原发性肝细胞癌组织中主要高甲基化肿瘤抑制基因的差异表达。
J Genet Eng Biotechnol. 2024 Sep;22(3):100394. doi: 10.1016/j.jgeb.2024.100394. Epub 2024 Jun 5.
3
Machine-Learning-Based Identification of Key Feature RNA-Signature Linked to Diagnosis of Hepatocellular Carcinoma.
基于机器学习的与肝细胞癌诊断相关的关键特征RNA标志物识别
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101456. doi: 10.1016/j.jceh.2024.101456. Epub 2024 Jun 14.
4
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment.酪蛋白及其衍生物的抗癌潜力:癌症治疗的新策略。
Med Oncol. 2024 Jul 11;41(8):200. doi: 10.1007/s12032-024-02403-8.
5
Chromosomal instability and inflammation: a catch-22 for cancer cells.染色体不稳定性和炎症:癌细胞的两难境地。
Chromosome Res. 2023 Aug 10;31(3):19. doi: 10.1007/s10577-023-09730-y.
6
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma.肿瘤微环境中 LAG-3 与 CD8 的免疫组化评分可预测肝细胞癌对免疫治疗的反应。
Front Immunol. 2023 Jun 5;14:1150985. doi: 10.3389/fimmu.2023.1150985. eCollection 2023.
7
Molecular programming modulates hepatic lipid metabolism and adult metabolic risk in the offspring of obese mothers in a sex-specific manner.分子编程以性别特异性方式调节肥胖母亲后代的肝脂质代谢和成年代谢风险。
Commun Biol. 2022 Oct 4;5(1):1057. doi: 10.1038/s42003-022-04022-3.
8
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.多激酶抑制剂阿法替尼可作为治疗人葡萄膜黑色素瘤的新型候选药物。
Cell Oncol (Dordr). 2022 Aug;45(4):601-619. doi: 10.1007/s13402-022-00686-5. Epub 2022 Jul 4.
9
Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells.酪氨酸激酶抑制剂通过增强肝癌细胞中的IFNγ/STAT1信号传导来刺激HLA I类分子表达。
Front Oncol. 2021 Aug 11;11:707473. doi: 10.3389/fonc.2021.707473. eCollection 2021.
10
Comprehensive analyses of potential key genes in active tuberculosis: A systematic review.全面分析活动性肺结核的潜在关键基因:系统综述。
Medicine (Baltimore). 2021 Jul 30;100(30):e26582. doi: 10.1097/MD.0000000000026582.